Cas9 specifies functional viral targets during CRISPR-Cas adaptation.
about
Evolutionary Ecology of Prokaryotic Immune MechanismsCRISPR/Cas9 therapeutics: a cure for cancer and other genetic diseasesAn Overview of CRISPR-Based Tools and Their Improvements: New Opportunities in Understanding Plant-Pathogen Interactions for Better Crop ProtectionDiversity of CRISPR-Cas immune systems and molecular machinesCurrent and future prospects for CRISPR-based tools in bacteriaBiogenesis pathways of RNA guides in archaeal and bacterial CRISPR-Cas adaptive immunityCRISPR-Cas: biology, mechanisms and relevanceMutations in Cas9 Enhance the Rate of Acquisition of Viral Spacer Sequences during the CRISPR-Cas Immune Response.Identifying and Visualizing Functional PAM Diversity across CRISPR-Cas SystemsAn updated evolutionary classification of CRISPR-Cas systems.CRISPR-Cas immunity in prokaryotes.Direct CRISPR spacer acquisition from RNA by a natural reverse transcriptase-Cas1 fusion protein.C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector.Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems.Application of CRISPR/Cas9 for biomedical discoveries.A newly discovered Bordetella species carries a transcriptionally active CRISPR-Cas with a small Cas9 endonuclease.Functional Analysis of Porphyromonas gingivalis W83 CRISPR-Cas Systems.ISC, a Novel Group of Bacterial and Archaeal DNA Transposons That Encode Cas9 Homologs.Comprehensive annotation of Glossina pallidipes salivary gland hypertrophy virus from Ethiopian tsetse flies: a proteogenomics approach.Casposon integration shows strong target site preference and recapitulates protospacer integration by CRISPR-Cas systemsDifferential Distribution of Type II CRISPR-Cas Systems in Agricultural and Nonagricultural Campylobacter coli and Campylobacter jejuni Isolates Correlates with Lack of Shared EnvironmentsForeign DNA acquisition by the I-F CRISPR-Cas system requires all components of the interference machinery.Just how Lamarckian is CRISPR-Cas immunity: the continuum of evolvability mechanisms.Polymorphism of CRISPR shows separated natural groupings of Shigella subtypes and evidence of horizontal transfer of CRISPR.Sensing danger.Degradation of Phage Transcripts by CRISPR-Associated RNases Enables Type III CRISPR-Cas Immunity.Complete Genome Sequence of Dolosigranulum pigrum from a Patient with Interstitial Lung Disease Using Single-Molecule Real-Time Sequencing Technology.DNA and RNA interference mechanisms by CRISPR-Cas surveillance complexes.The Discovery, Mechanisms, and Evolutionary Impact of Anti-CRISPRs.Impact of Different Target Sequences on Type III CRISPR-Cas Immunity.Naturally Occurring Off-Switches for CRISPR-Cas9.CRISPR: express delivery to any DNA address.Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA.CRISPR/Cas9: a promising way to exploit genetic variation in plants.Detecting natural adaptation of the Streptococcus thermophilus CRISPR-Cas systems in research and classroom settings.Deciphering, Communicating, and Engineering the CRISPR PAM.The CRISPR-Cas9 system in Neisseria spp.CRISPR-Cas: Adapting to change.Genome editing approaches: manipulating of lovastatin and taxol synthesis of filamentous fungi by CRISPR/Cas9 system.A decade of discovery: CRISPR functions and applications.
P2860
Q26740457-4E0439F2-EE5D-4B4D-89E9-C5DF946B648CQ26744172-4625FAA1-0B95-4CC2-A5D9-74B7F0CD9CC9Q26745534-EC174DB3-80E0-4FFE-8AAC-B8DA4B68CE2CQ26778564-8398C826-DD36-46B0-8B6A-F7C61DE72673Q26783837-48ACDC8F-8D83-4ECD-8226-C23A28ECF27EQ26853377-E7BCD6BA-407D-4762-BAF1-A7C1373937F7Q28069426-5047B213-E167-4EE2-B06F-F2A1B1F1D4DCQ30275154-6C40BBBC-E841-4282-992C-9B3AA1176972Q30740166-9D538B84-3BE4-4F91-AF01-41E11CF47805Q33660852-12E2EDAC-DF0D-4302-8AF0-39474AC95797Q34045076-0CB32183-7415-402D-B617-1130F0C6D6C8Q34046286-1C9A2220-3790-4718-A85F-482E515F4C3AQ34529451-9F8D5199-132F-4BC9-924C-062330EBCD34Q34536517-99553957-7CC0-4EDA-84ED-10BE5B691B06Q34671188-1E8C501B-4F3D-4D4C-84BA-636C52D91E20Q35821749-7FC25809-90A0-432E-9676-2C21CAA878E5Q35865998-356138D8-15BC-4EE7-BF5C-4A85147E5152Q35880291-881BC9F3-5A85-4171-BBD0-28F54FA7E0E7Q35902133-07EA5CE6-4931-420B-A45B-463FA8D04913Q36140262-7FC01166-7F16-467C-97F0-5BB7A8E640C0Q36166697-F62F0827-1808-4A3D-87FA-FE51C6FF5441Q36370853-E9B729D0-2529-432A-A1AE-32AD491BA1B1Q36611501-ADDC7031-DEF6-4D7C-9A5D-0FA4872F83E2Q36791488-5FFF629D-24A5-4C51-97CE-E9C533E37808Q37577192-EFC1464B-C19D-4D9F-98F4-E3FC002D6041Q38412720-A8EF45EF-1C95-40EA-AF9A-C61B5CD3EA49Q38431467-0EDFB39A-2CA7-44BD-BB68-DE22C614F1B5Q38454128-691B198A-373A-4826-AB90-F1704C649A01Q38651010-A61084AD-C60F-452B-B74D-C21AD6F734E0Q38694026-94C6E837-AD74-45E9-B76A-4707A83AA1BFQ38725824-92AB4D3A-391E-4992-942E-E7D227EE8137Q38797121-B517555F-3372-4A01-972C-F028CF8BBC73Q38801430-5BFBE1ED-A822-4DBA-B83A-5A17F4EC8134Q38939889-BEA455B1-EC38-4B15-9592-0B80EF47ACCAQ38957867-E150E4A7-E403-45A8-86AE-932666DAF3ACQ39028967-3618700D-AFEC-4124-BD70-E3A48A0A843CQ39215410-90CA44C8-73E1-4525-8BF1-97AA30FB043FQ39225316-62323407-9726-4B37-9F92-BA74D35D775EQ39227817-6AC0E804-9465-4DA2-B6FF-6C3346B503F0Q39350951-00C03269-05ED-493B-AAC9-D5F8D0E7C31A
P2860
Cas9 specifies functional viral targets during CRISPR-Cas adaptation.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Cas9 specifies functional viral targets during CRISPR-Cas adaptation.
@ast
Cas9 specifies functional viral targets during CRISPR-Cas adaptation.
@en
Cas9 specifies functional viral targets during CRISPR-Cas adaptation.
@nl
type
label
Cas9 specifies functional viral targets during CRISPR-Cas adaptation.
@ast
Cas9 specifies functional viral targets during CRISPR-Cas adaptation.
@en
Cas9 specifies functional viral targets during CRISPR-Cas adaptation.
@nl
prefLabel
Cas9 specifies functional viral targets during CRISPR-Cas adaptation.
@ast
Cas9 specifies functional viral targets during CRISPR-Cas adaptation.
@en
Cas9 specifies functional viral targets during CRISPR-Cas adaptation.
@nl
P2093
P2860
P356
P1433
P1476
Cas9 specifies functional viral targets during CRISPR-Cas adaptation
@en
P2093
Gregory W Goldberg
Joshua W Modell
Luciano A Marraffini
Poulami Samai
Robert Heler
P2860
P2888
P304
P356
10.1038/NATURE14245
P407
P577
2015-02-18T00:00:00Z
P5875
P6179
1012390199